Nervonik (Series A)
Funding Details
Awarder
Inbox
Date Award
March 5, 2025
Vertical
Neurological
Funding URL
View Funding Page
Funding Amount
$13,000,000
Company Info
Traction
Nervonik completed the first-in-human clinical study of its PNS device at the end of last year.
Founders
Aydin Babakhani
Market
Chronic Pain Management
Location
Los Angeles, California, USA
Coinvestors
Foothill Ventures, Correlation Ventures
Company Description

Nervonik is a startup focused on developing an opioid-free peripheral nerve stimulation (PNS) system designed to enhance therapy outcomes in the treatment of chronic pain. The device applies highly controlled electrical currents to peripheral nerves to modulate pain signals and provide pain relief.

Links
Website
Back to HomeBack to Neurological DealsView Funding Announcement